Kyverna Therapeutics, Inc. (KYTX) KPIs and segments
KYTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$4.70−0.06 (-1.26%)
Close on Nov 17, 2026Market cap $290.66MP/E –Yield –
KPIs & segments
Operating metrics and segments that drive Kyverna Therapeutics's business
Coming soon
This tab will track the numbers specific to Kyverna Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.
See a number that looks wrong?